Efficacy of Statin Addition to Neoadjuvant Chemotherapy Protocols for Breast Cancer
Status:
Not yet recruiting
Trial end date:
2021-12-15
Target enrollment:
Participant gender:
Summary
Different modalities for breast cancer treatments have exhausting and distressing side
effects and toxicities leading to decreased compliance. Thus, repurposing drugs with accepted
safety profile and possible antitumor activity becomes an eminent constraint.
Statins have been reported to have possible advantages as anticancer, and control of cancer
progression. Moreover, they can sensitize cancer cells for radiotherapy. Therefore, the
investigators aim to investigate the effect of (pitavastatin) added to conventional
chemotherapy protocols for breast cancer patients.